Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 9, 2011 | CeNeRx BioPharma | $4.8M Other Equity | — | L Capital Partners, Omega Funds, Pappas Ventures |
| Jun 10, 2011 | Ambit Pharmaceuticals | $30.0M Series D | Allan Marchington | Forward Ventures, Genechem, Gimv, GrowthWorks, Horizon Technology Finance, MedImmune Ventures, NovaQuest Capital Management, OrbiMed, Radius Ventures, Roche |
| Aug 13, 2010 | CeNeRx BioPharma | $13.0M Series C | — | L Capital Partners, Pappas Ventures |
| Nov 1, 2007 | Ambit Biosciences | $49.0M Series D | — | OrbiMed, Allan Marchington, Avalon Ventures, Standish Fleming, Genechem, Gimv, Horizon Technology Finance, Jov-CMDF, David Mott, NovaQuest Capital Management, Radius Ventures, Roche |